Antihypertensive drug therapy in USAF flying personnel.
The reviewed data concerns hypertensive USAF aircrew members, as available from the WAVR File (July 1973) and the records of the Aeromedical Consultation Service at USAFSAM (1 July 1972-30 June 1973). Of over 6,500 entries in the WAVR File, hypertension was listed as a diagnosis for 754 individuals. Drug therapy had been instituted in 379 cases (50.3%) of the total. Statistics regarding ranks, age groups, and aeronautical ratings are presented. The group included 520 pilots, of whom 268 were receiving drug therapy. Associated medical conditions, e.g., abnormal EKG findings, carbohydrate intolerance, and hyperuriciemia, are presented. Similar data are reviewed for the 84 patients evaluated on the Aeromedical Consultation Service (USAFSAM).
D000328:Adult; D000337:Aerospace Medicine; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004562:Electrocardiography; D006471:Gastrointestinal Hemorrhage / Q000150:complications; D005947:Glucose / Q000378:metabolism; D005951:Glucose Tolerance Test; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D007674:Kidney Diseases / Q000150:complications; D008659:Metabolic Diseases / Q000139:chemically induced; D012189:Retrospective Studies; D014481:United States; D014527:Uric Acid / Q000097:blood
D000959:Antihypertensive Agents; D014527:Uric Acid; D005947:Glucose